| 1. |
Dr. Arthur Lo, Theravance, to Discuss a Viral Kinetics Model for Optimizing Compound Selection and Predicting Efficacy in Rosa’s Impact Webinar Series
|
| 2. |
Dr. Toufigh Gordi to discuss the Selection of Appropriate Mathematical Modeling Techniques in Drug Development at 4th World PK/PD Summit
|
| 3. |
Dr. Pratap Singh, to Discuss PK/PD Modeling Analysis of a Compound Targeting Muscle Growth in Rosa’s Impact Webinar Series
|
| 4. |
Dr. Malcolm Rowland, to Discuss Physiologically-Based Pharmacokinetics in Rosa’s Impact Webinar Series
|
| 5. |
GlaxoSmithKline and Rosa Present Psoriasis Collaboration Results at 17th International IRA Conference
|
| 6. |
Rosa to Present Mechanistic Systems Pharmacology Workshop at 2012 ICSB Conference
|
| 7. |
Rosa to Present at 2012 PaSiPhIC Conference
|
| 8. |
Dr. Scott Siler to Discuss DILIsym Model in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
|
| 9. |
Rosa to Present Beta Cell Mass Research at 2012 ADA Annual Meeting
|
| 10. |
Dr. Toufigh Gordi to Discuss Pediatric PK Model in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
|
| 11. |
Rosa to present two lectures at The European Foundation of Medicinal Chemists Conference
|
| 12. |
Rosa to Present Systems Pharmacology Workshop at 3rd Annual World PK/PD Summit
|
| 13. |
Rosa to Present at 2012 Keystone Symposia: Advances in Islet Biology
|
| 14. |
Dr. Joga Gobburu to Discuss the Impact of Pharmacometrics on Drug Approvals in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
|
| 15. |
Rosa PK/PD Collaboration with Pfizer to be Presented at ASCPT 2012
|
| 16. |
Rosa Announces Publication of its PhysioPD™ Model Qualification Method and Series of Educational Events
|
| 17. |
Biopontis Alliance Fund and Rosa Announce Strategic Relationship for Early Stage Drug Development
|
| 18. |
Dr. Hartmut Derendorf to Discuss PK/PD-based Drug Development in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
|
| 19. |
Rosa to present at 2012 Keystone Symposia: Cancer and Metabolism
|
| 20. |
Dr. Mike Reed to Participate in Roundtable Panel of American Society of Phamacometrics
|
| 21. |
Pfizer and Rosa to present at 2012 Keystone Symposia: Pathogenesis of Diabetes
|
| 22. |
Rosa’s Toufigh Gordi to Present at 2nd Annual Pediatric Pharmacology Conference 2012
|
| 23. |
Dr. Tristan Maurer to Discuss Translational Modeling in Support of Drug Discovery in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
|
| 24. |
Dr. Mike Reed Joins Rosa & Co. Executive Management Team
|
| 25. |
Dr. Nick Holford to Discuss the Use of Modeling in Clinical Pharmacology in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
|
| 26. |
Rosa’s Christina Friedrich to Lead Model Qualification Workshop at ICSB 2011
|
| 27. |
Dr. Rebecca Baillie to Describe PhysioPD™ Model Construction and Testing in Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
|
| 28. |
Rosa and FOCUS-IP Announce Strategic Alliance for Enhancing Proof-of-Concept Drug Development and Licensing Opportunities
|
| 29. |
Rosa Announces Qualification of a Novel Methodology for Prediction of Pediatric Clinical Pharmacology Data in Bile Acid Metabolism
|
| 30. |
Rosa Diabetes PhysioPD™ Collaboration with Pfizer to be Presented at World PK/PD Summit
|
| 31. |
Head of the US FDA Division of Pharmacometrics to Kick-off Rosa’s World-Wide Webinar Series, “Impact of Modeling & Simulation in Drug Development”
|
| 32. |
Rosa Announces Six Poster Presentations at the American College on Pharmacometrics 2011
|
| 33. |
Rosa & Co. Announces the Appointment of Sharan A. Pagano as Vice President, Scientific Alliances, and the Opening of Rosa’s Boston-area Office
|
| 34. |
Rosa & Co and Vitalea Science to present at ASPCT 2011 meeting
|
